Does this order affect TOMI's current sales guidance or outlook for the year?

Answer

The press release only announces that TOMI has landed a “significant” order from ARES Distribution. It does not state that the deal was incorporated into the company’s existing sales‑guidance model or that the revenue run‑rate from the order will be reflected in the current 2025 outlook. Consequently, from a fundamental standpoint the order is an incremental boost to the top line rather than a revision of the guidance already issued for the year.

From a market‑reaction perspective, the news is likely to generate a modest short‑term upside in the stock as investors price in the incremental revenue and the validation of TOMO’s commercial traction. However, because the guidance envelope remains unchanged, the broader upside is limited to the incremental contribution of the ARES deal (i.e., a modest lift to quarterly revenue and possibly a slight beat‑to‑budget in the next reporting period). Technically, the stock may test the next resistance level around the recent high‑range (≈ $0.90‑$1.00) on the basis of the news flow, but a sustained rally would require a formal upgrade to the sales outlook.

Trading implication:

- Short‑term: Consider a modest long‑biased position (e.g., buying on dips near the current support) with a target at the next resistance level, reflecting the incremental revenue boost.

- Medium‑term: Hold the position unless TOMI issues a formal guidance update that incorporates the ARES order; without a guidance lift, the upside remains bounded.